- MDGL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Madrigal Pharmaceuticals (MDGL) 10-K/A2015 FY Annual report (amended)
Filed: 29 Apr 16, 12:00am
EXHIBIT 31.1.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF
SARBANES-OXLEY ACT OF 2002
I, Chen Schor, certify that:
1. I have reviewed this Annual Report on Form 10-K of Synta Pharmaceuticals Corp.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: April 29, 2016 | /s/ CHEN SCHOR |
| Chen Schor |
| President and Chief Executive Officer |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.